See inside every stock. Pro
WatchlistPro
S&P 5007,377▲ 0.31%Nasdaq24,579▲ 1.09%Dow Jones51,286▼ 0.46%Nasdaq 10026,990▲ 1.35%VIX25.64▼ 9.01%US Dollar102.28▲ 0.72%Gold spot4,066▼ 0.49%WTI90.83▲ 0.34%

SPDR S&P Pharmaceuticals (XPH)

Healthcare ETF · State Street (SPDR) · NYSE ARCA · 67 holdings
$64.75 ▲ +2.10 (3.35%)
At close · USD · Volume 171,100
Returns and riskCostIncomeDividend historyHoldingsQuestions
52-week range
$47.60 – $74.35
Day's range
$62.97 – $65.05
1-year total return
+33.9%

XPH price chart

Daily, split-corrected, distributions markedEnd-of-day prices

XPH fund facts

FundSPDR® S&P Pharmaceuticals ETF
TickerXPH · NYSE ARCA
Issuer (by our rules)State Street (SPDR)
Category (by our rules)Healthcare
Expense ratio0.35%
Holdings67
Net assets (fund, SEC)$428M
Yield (last 12 months)0.42%
DistributionsQuarterly
52-week range$47.60 – $74.35
Average volume (3 months)193,612
First price in our data22 Jun 2006
Issuer and category are assigned by StocksXray rules from the fund name. Expense ratio and net assets come from SEC filings; where a fund does not file them (for example grantor trusts) the field stays empty.

Returns and risk

1 month
+2.9%
3 months
−7.9%
6 months
+6.8%
Year to date
+15.9%
1 year
+33.9%
3 years a year
+21.9%
5 years a year
+5.9%
10 years a year
+6.6%
Volatility (1 year)
24.3%
Largest drop, last year
−16.5%
Largest drop in our data
−48.0%
Total return includes distributions, from end-of-day prices adjusted for splits and distributions, to 6 Nov 2026. Periods of 3 years and longer are annualised and shown only when the fund's history is long enough. Volatility is the standard deviation of daily returns over the last year, annualised. Past performance does not guarantee future results.

Cost: expense ratio

0.35% a year

On $10,000 invested that is about $35 a year in fund costs, taken out of the fund's assets.

Source: the fund's prospectus, as filed with the SEC on 24 Oct 2025 (risk/return summary data). Brokerage commissions and the bid-ask spread are separate costs.

Income: distributions

Paid, last 12 months
0.28 USD
Yield on today's price
0.42%
Frequency
Quarterly
Latest ex-date
21 Sep 2026
Full XPH dividend history →
Cash paid per current share (restated for share splits), before tax, from our market-data provider.

XPH top holdings

#HoldingWeight
1 State Street Global Advisors 8.58%
2 Definium Therapeutics Inc 3.09%
3 MBX Biosciences Inc 2.72%
4 Alumis Inc 2.14%
5 AtaiBeckley Inc 2.13%
6 Trevi Therapeutics Inc 2.12%
7 Enliven Therapeutics Inc 2.09%
8 Amylyx Pharmaceuticals Inc 2.04%
9 VeraDermics Inc 2.02%
10 Ligand Pharmaceuticals Inc 1.94%
The top 10 make up 28.9% of the fund, out of 67 holdings.
Positions as of 30 Jun 2026, from the fund's Form N-PORT filed with the SEC. Public N-PORT holdings are quarter-end positions published about 60 days later, so they can be months old and the fund may have changed since.

Similar Healthcare ETFs

IXJ iShares Global Healthcare0.40% fee · +24.8% 1y IHF iShares U.S. Healthcare Provid...0.38% fee · +25.1% 1y IHE iShares U.S. Pharmaceuticals0.38% fee · +41.6% 1y FHLC Fidelity MSCI Health Care Inde...0.08% fee · +27.5% 1y IYH iShares U.S. Healthcare0.38% fee · +27.8% 1y VHT Vanguard Health Care0.09% fee · +27.4% 1y All healthcare ETFs →
Funds of the same category, nearest in trading size. Similar does not mean equivalent: check holdings and costs.

XPH: frequently asked questions

What is XPH?

XPH is the SPDR S&P Pharmaceuticals ETF, issued by State Street (SPDR), listed on NYSE ARCA. By our rules it is classed as "Healthcare". Its latest SEC filing lists 67 holdings.

What is the expense ratio of XPH?

XPH charges 0.35% a year, according to its prospectus filed with the SEC on 24 Oct 2025. On $10,000 that is about $35 a year in fund costs.

Does XPH pay dividends?

Yes. XPH paid 0.28 per share over the last 12 months, quarterly, a trailing yield of 0.42% on today's price. The latest ex-dividend date was 21 Sep 2026.

What does XPH hold?

The largest holdings in the latest SEC filing are State Street Global Advisors (8.6%), Definium Therapeutics Inc (3.1%), MBX Biosciences Inc (2.7%). The top 10 together make up 28.9% of the fund.

How has XPH performed?

Total return including distributions to 6 Nov 2026: 1 year +33.9%, 3 years +21.9% a year, 5 years +5.9% a year. Past performance does not guarantee future results.

Where the numbers come from

Prices and distributions end-of-day data from our market-data provider; returns are our own calculations from it.
Expense ratio and holdings SEC filings (prospectus risk/return data and Form N-PORT).
Category, issuer and leverage assigned by StocksXray rules from the fund name.
X-Ray look-through our scores applied to the SEC holdings.
Read the methodology →

StocksXray is for education only and is not financial advice or a recommendation to buy or sell anything. Past performance does not guarantee future results; funds can lose value.